Alpha 2.0
Login Register
» Authors » Margriet Collee

Margriet Collee

Explore the profile of Margriet Collee including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 1753
Followers 0
Related Specialties
Oncology
Genetics
General Medicine
Top 10 Co-Authors
Christi J van Asperen
Margreet G E M Ausems
Maartje J Hooning
Annegien Broeks
Marjanka K Schmidt
Graham G Giles
Peter A Fasching
Flora E van Leeuwen
Peter Devilee
Hiltrud Brauch
Published In
PLoS One
Breast Cancer Res Treat
Nat Genet
Eur J Hum Genet
Fam Cancer
Affiliations
Soon will be listed here.
Recent Articles
1.
Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank
Zelisse H, van Gent M, Mom C, de Ridder S, Snijders M, Heeling M, et al.
Ann Diagn Pathol . 2024 Nov; 74:152411. PMID: 39591762
Fundamental and translational research in ovarian cancer aims to enhance understanding of disease mechanisms and improve treatment and survival outcomes. To support this, we established the Dutch multicenter, interdisciplinary Archipelago...
2.
Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant
Terra L, Boekel N, Hooning M, Collee M, Schmidt M, Adank M, et al.
Breast Cancer Res Treat . 2024 Nov; 209(3):573-583. PMID: 39482556
Purpose: Breast cancer (BC) treatment can induce adverse events, such as cardiovascular disease (CVD). Defective DNA repair, as in carriers of BRCA1/2 pathogenic variants (BRCA1/2pv), may contribute to CVD risk....
3.
The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks
Zelisse H, de Ridder S, van Gent M, Mom C, Wisman G, Roes E, et al.
Biopreserv Biobank . 2024 Apr; 22(6):568-577. PMID: 38682281
Biobanks play a crucial role in fundamental and translational research by storing valuable biomaterials and data for future analyses. However, the design of their information technology (IT) infrastructures is often...
4.
Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research
Zelisse H, van Gent M, de Ridder S, van der Aa M, Van Altena A, Bart J, et al.
Gynecol Obstet Invest . 2022 Nov; 87(6):389-397. PMID: 36450222
Objectives: Ovarian cancer has the worst overall survival rate of all gynecologic malignancies. For the majority of patients, the 5-year overall survival rate of less than 50% has hardly improved...
5.
Effect of a health literacy training program for surgical oncologists and specialized nurses on disparities in referral to breast cancer genetic testing
van der Giessen J, van Dulmen S, Velthuizen M, van den Muijsenbergh M, van Engelen K, Collee M, et al.
Breast . 2021 May; 58:80-87. PMID: 33933926
Background: There is an underuse of genetic testing in breast cancer patients with a lower level of education, limited health literacy or a migrant background. We aimed to study the...
6.
Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study)
Terra L, Hooning M, Heemskerk-Gerritsen B, van Beurden M, Roeters van Lennep J, van Doorn H, et al.
JMIR Res Protoc . 2021 Jan; 10(1):e24414. PMID: 33480862
Background: BRCA1/2 mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) at 35 to 45 years of age. RRSO substantially decreases ovarian cancer risk, but at the cost of immediate...
7.
Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making
Reumkens K, Tummers M, Severijns Y, Gietel-Habets J, van Kuijk S, Aalfs C, et al.
J Community Genet . 2020 Sep; 12(1):101-110. PMID: 32880035
Individuals having a genetic predisposition to cancer and their partners face challenging decisions regarding their wish to have children. This study aimed to determine the effects of an online decision...
8.
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Heemskerk-Gerritsen B, Jager A, Koppert L, Obdeijn A, Collee M, Meijers-Heijboer H, et al.
Breast Cancer Res Treat . 2019 Jul; 177(3):723-733. PMID: 31302855
Background: In healthy BRCA1/2 mutation carriers, bilateral risk-reducing mastectomy (BRRM) strongly reduces the risk of developing breast cancer (BC); however, no clear survival benefit of BRRM over BC surveillance has...
9.
Online decision support for persons having a genetic predisposition to cancer and their partners during reproductive decision-making
Reumkens K, Tummers M, Gietel-Habets J, van Kuijk S, Aalfs C, van Asperen C, et al.
J Genet Couns . 2019 Jan; 28(3):533-542. PMID: 30629779
A nationwide pretest-posttest study was conducted in all clinical genetic centres in the Netherlands, to evaluate the effects of an online decision aid to support persons who have a genetic...
10.
Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers
Derks-Smeets I, Schrijver L, de Die-Smulders C, Tjan-Heijnen V, van Golde R, Smits L, et al.
Br J Cancer . 2018 Jun; 119:357-363. PMID: 29937543
Background: The effect of in vitro fertilisation (IVF) on breast cancer risk for BRCA1/2 mutation carriers is rarely examined. As carriers may increasingly undergo IVF as part of preimplantation genetic...